158 related articles for article (PubMed ID: 20055782)
41. [Acute bacterial rhinosinusitis: current approaches to diagnosis and antibacterial therapy in out patient setting (recommendations of American Academy of otolaryngology, head and neck surgery, American Association of rhinologists, American Academy of ENT allergic diseases, 2000, Clinical consultative Committee for sinusitis in children and adults, 2000, American Academy of pediatrics, 2001, Center of disease and control, USA, 2001)].
Tarasov AA; Kamanin EI; Kriukov AI; Strachunskiĭ LS
Vestn Otorinolaringol; 2003; (2):46-54. PubMed ID: 12958867
[No Abstract] [Full Text] [Related]
42. Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis.
Small CB; Bachert C; Lund VJ; Moscatello A; Nayak AS; Berger WE
Am J Med; 2007 Apr; 120(4):289-94. PubMed ID: 17398218
[TBL] [Abstract][Full Text] [Related]
43. Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis.
Olivieri D; Del Donno M; Casalini A; D'Ippolito R; Fregnan GB
Respiration; 1991; 58(2):91-4. PubMed ID: 1862257
[TBL] [Abstract][Full Text] [Related]
44. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
Cazzola M; Floriani I; Page CP
Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
[TBL] [Abstract][Full Text] [Related]
45. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial.
Weschta M; Rimek D; Formanek M; Polzehl D; Podbielski A; Riechelmann H
J Allergy Clin Immunol; 2004 Jun; 113(6):1122-8. PubMed ID: 15208594
[TBL] [Abstract][Full Text] [Related]
46. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis.
Brook I
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313
[No Abstract] [Full Text] [Related]
47. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and tolerability of systemic methylprednisolone in children and adolescents with chronic rhinosinusitis: a double-blind, placebo-controlled randomized trial.
Ozturk F; Bakirtas A; Ileri F; Turktas I
J Allergy Clin Immunol; 2011 Aug; 128(2):348-52. PubMed ID: 21624649
[TBL] [Abstract][Full Text] [Related]
49. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
51. Nasal saline irrigation with or without systemic antibiotics in treatment of children with acute rhinosinusitis.
Ragab A; Farahat T; Al-Hendawy G; Samaka R; Ragab S; El-Ghobashy A
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2178-86. PubMed ID: 26514931
[TBL] [Abstract][Full Text] [Related]
52. Similar effect of therapeutic ultrasound and antibiotics for acute bacterial rhinosinusitis: a randomised trial.
Høsøien E; Lund AB; Vasseljen O
J Physiother; 2010; 56(1):29-32. PubMed ID: 20500134
[TBL] [Abstract][Full Text] [Related]
53. Erdosteine.
Dechant KL; Noble S
Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
[TBL] [Abstract][Full Text] [Related]
54. Acute sinusitis.
Feldt B; Dion GR; Weitzel EK; McMains KC
South Med J; 2013 Oct; 106(10):577-81. PubMed ID: 24096952
[TBL] [Abstract][Full Text] [Related]
55. Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial.
Chang AB; Yerkovich ST; Baines KJ; Burr L; Champion A; Chatfield MD; Eg KP; Goyal V; Marsh RL; McCallum GB; McElrea M; McPhail S; Morgan LC; Morris PS; Nathan AM; O'Farrell H; Sanchez MO; Parsons M; Schultz A; Torzillo PJ; West NP; Versteegh L; Marchant JM; Grimwood K
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38719503
[TBL] [Abstract][Full Text] [Related]
56. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
57. Effects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung disease.
Marchioni CF; Moretti M; Muratori M; Casadei MC; Guerzoni P; Scuri R; Fregnan GB
Lung; 1990; 168(5):285-93. PubMed ID: 2126836
[TBL] [Abstract][Full Text] [Related]
58. Amoxicillin for acute rhinosinusitis: a randomized controlled trial.
Garbutt JM; Banister C; Spitznagel E; Piccirillo JF
JAMA; 2012 Feb; 307(7):685-92. PubMed ID: 22337680
[TBL] [Abstract][Full Text] [Related]
59. Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD.
Dal Negro RW; Visconti M; Micheletto C; Tognella S
Pulm Pharmacol Ther; 2008; 21(2):304-8. PubMed ID: 17889580
[TBL] [Abstract][Full Text] [Related]
60. Patients' expectations about the benefit of antibiotic treatment: lessons from a randomised controlled trial.
Young J; Hugenschmidt C; Welge-Lüssen A; Bucher HC; Tschudi P; Périat P
Forsch Komplementarmed Klass Naturheilkd; 2005 Dec; 12(6):347-9. PubMed ID: 16391484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
